- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
A prognosis model for clear cell renal cell carcinoma based on four necroptosis-related genes.
August 30, 2022
Assessing Trifecta Achievement after Percutaneous Cryoablation of Small Renal Masses: Results from a Multi-Institutional Collaboration.
August 30, 2022
Adding Cyclooxygenase Inhibitors to Immune Checkpoint Inhibitors Did Not Improve Outcomes in Metastatic Renal Cell Carcinoma.
August 30, 2022
The Role of Cytoreductive Nephrectomy in Renal Cell Carcinoma with Sarcomatoid Histology: A Case Series and Review of the Literature.
August 30, 2022
Construction and validation of a novel ten miRNA-pair based signature for the prognosis of clear cell renal cell carcinoma.
August 29, 2022
Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.
August 29, 2022
Analysis of Trifecta Results in a Single-Center Experience with Retroperitoneoscopic Partial Nephrectomy: An Observational Study.
August 26, 2022
BAP1 maintains HIF-dependent interferon beta induction to suppress tumor growth in clear cell renal cell carcinoma.
August 24, 2022
C-reactive protein provides superior prognostic accuracy than the IMDC risk model in renal cell carcinoma treated with Atezolizumab/Bevacizumab.
August 23, 2022
Surgical waiting times and all-cause mortality in patients with non-metastatic renal cell carcinoma.
August 23, 2022
Analysis and Prediction of the Survival Trends of Patients with Clear-Cell Renal Cell Carcinoma: A Model-Based Period Analysis, 2001-2015.
August 22, 2022
Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas.
August 22, 2022
Deep learning can predict survival directly from histology in clear cell renal cell carcinoma.
August 19, 2022